Detailed mechanistic studies reveal that KAT2B interacts with the transcription factor SP1 to induce the expression of the tumor suppressor gene NF2 in CCA cells, which leads to inhibition of oncogenic YAP signaling (Fig. 7J). The gene discussed is KAT2B; the disease is cholangiocarcinoma.